Publications en collaboration avec des chercheurs de Centre Hospitalier de l’Université de Montréal (63)

2024

  1. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

    JAMA Neurology, Vol. 80, Núm. 7, pp. 702-713

  3. Correction: Lymph node metastasis in level IIb in oropharyngeal squamous cell carcinoma: a multicentric, longitudinal, retrospective analysis (European Archives of Oto-Rhino-Laryngology, (2023), 280, 2, (869-876), 10.1007/s00405-022-07647-6)

    European Archives of Oto-Rhino-Laryngology

  4. Disability accrual in primary and secondary progressive multiple sclerosis

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 94, Núm. 9, pp. 707-717

  5. Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial

    Journal of neurology, neurosurgery, and psychiatry, Vol. 94, Núm. 12, pp. 1004-1011

  6. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  7. Influence of Otolaryngological Subspecialties on Perception of Transoral Robotic Surgery: An International YO-IFOS Survey

    Journal of Personalized Medicine, Vol. 13, Núm. 12

  8. Lymph node metastasis in level IIb in oropharyngeal squamous cell carcinoma: a multicentric, longitudinal, retrospective analysis

    European Archives of Oto-Rhino-Laryngology, Vol. 280, Núm. 2, pp. 869-876

  9. Non-Squamous Cell Carcinoma of the Larynx: A State-of-the-Art Review

    Journal of Personalized Medicine, Vol. 13, Núm. 7

  10. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

    Brain : a journal of neurology, Vol. 146, Núm. 11, pp. 4633-4644

2022

  1. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

    Neurology, Vol. 99, Núm. 17, pp. E1926-E1944

  2. Epidemiological, clinical and oncological outcomes of young patients with laryngeal cancer: a systematic review

    European Archives of Oto-Rhino-Laryngology, Vol. 279, Núm. 12, pp. 5741-5753

  3. Features of Mild-to-Moderate COVID-19 Patients With Dysphonia

    Journal of Voice, Vol. 36, Núm. 2, pp. 249-255

  4. Gracilis free flap in head and neck reconstruction beyond facial palsy reanimation

    Acta Otorrinolaringologica Espanola, Vol. 73, Núm. 5, pp. 310-322

  5. Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 94, Núm. 1, pp. 23-30

  6. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

    Scientific Data, Vol. 9, Núm. 1

  7. Machine Learning Algorithms as a Computer-Assisted Decision Tool for Oral Cancer Prognosis and Management Decisions: A Systematic Review

    ORL, Vol. 84, Núm. 4, pp. 278-288

  8. Management of oral feeding following total laryngectomy around the world: YO-IFOS international study

    Head and Neck, Vol. 44, Núm. 8, pp. 1755-1764

  9. Patterns of practice regarding surgical site infection prevention in head & neck surgery: An international survey

    Acta Otorrinolaringologica Espanola, Vol. 73, Núm. 4, pp. 225-234